Swedish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
thyroid neoplasms/huvudvärk
Länken sparas på Urklipp
Sida 1 från 49 resultat
Recombinant thyroid-stimulating hormone in differentiated thyroid cancer.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Recombinant TSH is effective in providing exogenous TSH stimulation for patients with differentiated thyroid cancer on thyroid hormone-suppressive therapy. It allows for detection of thyroid remnant and metastases by radioiodine scan and by serum thyroglobulin determination. The sensitivity and
Circulating nitric oxide is modulated by recombinant human TSH administration during monitoring of thyroid cancer remnant.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
During the administration of recombinant human TSH (rhTSH) to monitor differentiated thyroid carcinoma, mild side effects, such as nausea and headaches, often occur. The origin of these is not clear. Since changes in TSH and thyroid hormones can modulate some endothelial-derived factors, we aimed at
Off-label use of sunitinib in patients with advanced, epithelial thyroid cancer: a retrospective analysis.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Tyrosine kinase receptors play an important role in tumor angiogenesis and, their implication in epithelial thyroid tumor growth has been highlighted. Sunitinib is a novel tyrosine kinase inhibitor, approved in 2006 by Food and Drug Administration for the treatment of advanced renal cell and
The use of recombinant thyrotropin in the follow-up of patients with differentiated thyroid cancer.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Many clinicians care for patients who have been treated for differentiated thyroid cancer. Recombinant thyrotropin, which stimulates iodine uptake in thyroid tissue, is a safe and effective diagnostic agent for those patients who require radioiodine scanning for routine follow-up. The combination of
Complete endoscopic radical resection of thyroid cancer via an oral vestibule approach.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
The aim of the present study was to explore the feasibility, safety and effectiveness of complete endoscopic radical resection of thyroid cancer via an oral vestibule approach. A total of 60 patients with unilateral thyroid papillary carcinoma were divided into two groups. Half of them underwent
Recombinant human thyrotropin (rhTSH) in the management of differentiated thyroid cancer.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Recombinant human thyrotropin (rhTSH) has been evaluated in 38 patients with differentiated thyroid cancer. The patients had all been treated previously by operation and 31 had received radioiodine 131I. The patients continued to take thyroid hormone and changed to a low iodine diet for 14 days
Follicular thyroid cancer presenting as a sellar mass: case report and review of the literature.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
OBJECTIVE
To describe an uncommon initial manifestation of well-differentiated follicular carcinoma of the thyroid in an unusual metastatic site.
METHODS
We present clinical, laboratory, and imaging findings in our patient and review related data from the literature.
RESULTS
A young healthy woman
From childhood migraine headache to pheochromocytoma.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Pheochromocytoma may have multiple clinical manifestations including paroxysmal hypertension, tachycardia, sweating, nausea, and headache (Phillips et al., 2002). Migraine has some of the manifestations seen with pheochromocytoma. We describe a patient who had a history of migraine headaches since
Occipital Condyle Syndrome Caused by Isolated Bone Metastases from Thyroid Cancer.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Occipital condyle syndrome is a rare cause of pain in the head which is characterized by severe and persistent unilateral suboccipital headache with unilateral hypoglossal nerve palsy. We report an elderly female who presented with dysarthria and suboccipital headache. On further evaluation, she was
Health profiles and quality of life of 518 survivors of thyroid cancer.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND
Available literature describes the long-term outcome of thyroid cancer survivors with respect to thyroid cancer but not their overall medical and social well-being.
METHODS
Five hundred eighteen thyroid cancer survivors responded to a survey regarding medical and social impacts of their
Vandetanib: a novel targeted therapy for the treatment of metastatic or locally advanced medullary thyroid cancer.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
OBJECTIVE
The pharmacology, pharmacokinetics, efficacy, safety and tolerability, drug and food interactions, cost, and place in therapy of vandetanib are reviewed.
CONCLUSIONS
Vandetanib is a small-molecule inhibitor of vascular endothelial growth factor receptor, epidermal growth factor receptor,
Using recombinant human thyroid-stimulating hormone for the diagnosis of recurrent thyroid cancer.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND
Recombinant human thyroid-stimulating hormone (rhTSH) has been suggested as a diagnostic agent in the diagnosis of recurrent thyroid cancer, instead of the current practice of thyroid hormone (THT) withdrawal.
METHODS
An evidenced-based literature review was used as the basis for a
Thyroid Cancer-Specific Quality of Life and Health-Related Quality of Life in Young Adult Thyroid Cancer Survivors.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
There is a lack of health-related quality of life (HRQOL) research in thyroid cancer (TC) survivors, especially young adults (YAs). This study aims to assess the socio-demographic and clinical factors that most influence TC-specific QOL domains and estimate the impact of different health conditions
Concurrent papillary thyroid cancer with pituitary ACTH-secreting tumor.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Concomitant thyroid cancer with pituitary tumor is uncommon. This study reports a case of advanced papillary thyroid carcinoma with pituitary adrenocorticotropic hormone (ACTH)-secreting tumor. A 58-year-old male patient had thyroid cancer in 1991 and presented with headache caused by pituitary
Vandetanib therapy in medullary thyroid cancer.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
The U.S. Food and Drug Administration (FDA) approved vandetanib in April 2011 for the treatment of unresectable, locally advanced or metastatic medullary thyroid cancer (MTC). In Europe it was approved in March 2012, but only for the treatment of aggressive and symptomatic MTC. This small molecule
Den mest kompletta databasen med medicinska örter som stöds av vetenskapen
- Fungerar på 55 språk
- Växtbaserade botemedel som stöds av vetenskap
- Örter igenkänning av bild
- Interaktiv GPS-karta - märka örter på plats (kommer snart)
- Läs vetenskapliga publikationer relaterade till din sökning
- Sök efter medicinska örter efter deras effekter
- Organisera dina intressen och håll dig uppdaterad med nyheterna, kliniska prövningar och patent
Skriv ett symptom eller en sjukdom och läs om örter som kan hjälpa, skriv en ört och se sjukdomar och symtom den används mot.
* All information baseras på publicerad vetenskaplig forskning
